MALIGNANT GLIOMA

general

A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.

75

Centers

338

Active Trials

$754M

Cancer Funding

Specific Cancer Types(4)

Top Centers for MALIGNANT GLIOMA(75)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Clinical
High-Volume Research Center
86.8
2
NCI Comprehensive
High-Volume Research Center
81.1
3
NCI Comprehensive
High-Volume Research Center
77.4
4
NCI Comprehensive
High-Volume Research Center
75.5
5
NCI Comprehensive
High-Volume Research Center
71.5
6
NCI Comprehensive
High-Volume Research Center
70.1
7
NCI Comprehensive
Active Research Program
69.6
8
NCI Comprehensive
Active Research Program
67.7
9
NCI Comprehensive
Active Research Program
66.2
10
NCI Comprehensive
Active Research Program
66.2
11
Active Research Program
66.2
12
Active Research Program
66.2
13
Active Research Program
66.2
14
NCI Comprehensive
Active Research Program
65.3
15
NCI Comprehensive
Active Research Program
61.6
16
NCI Comprehensive
Active Research Program
61.6
17
NCI Comprehensive
Active Research Program
61.6
18
Active Research Program
61.6
19
Active Research Program
61.6
20
Active Research Program
61.6
21
NCI Clinical
Active Research Program
58.3
22
NCI Comprehensive
Active Research Program
56.2
23
NCI Comprehensive
Active Research Program
55.3
24
NCI Comprehensive
Active Research Program
54.8
25
NCI Comprehensive
Active Research Program
54.3
26
NCI Comprehensive
Active Research Program
52.9
27
Active Research Program
52.6
28
NCI Comprehensive
Active Research Program
52.4
29
NCI Comprehensive
Active Research Program
52.4
30
NCI Comprehensive
Active Research Program
52.4
31
NCI Comprehensive
Active Research Program
52.4
3252.4
33
NCI Comprehensive
Active Research Program
52.4
34
Active Research Program
52.4
35
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
52.4
36
Active Research Program
52.4
37
NCI Comprehensive
Active Research Program
52.4
38
NCI Clinical
Active Research Program
52.4
39
NCI Clinical
Active Research Program
52.4
40
Active Research Program
52.4
41
Active Research Program
52.4
42
Active Research Program
52.4
43
Active Research Program
52.4
44
Active Research Program
52.4
45
NCI Comprehensive
Active Research Program
45.5
46
NCI Comprehensive
Active Research Program
45.0
47
NCI Comprehensive
Active Research Program
43.6
48
NCI Comprehensive
Active Research Program
43.1
49
NCI Comprehensive
Active Research Program
42.8
50
NCI Comprehensive
Active Research Program
42.8
51
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
42.8
52
NCI Comprehensive
Active Research Program
42.8
53
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
42.8
5442.8
5542.8
56
Active Research Program
42.8
57
NCI Comprehensive
Active Research Program
38.2
58
NCI Comprehensive
Active Research Program
38.2
59
Active Research Program
38.2
60
BC CancerVancouver, BC
Active Research Program
38.2
61
NCI Comprehensive
Contributing Research Center
33.3
62
NCI Comprehensive
Contributing Research Center
33.3
63
NCI Comprehensive
Contributing Research Center
33.3
64
NCI Comprehensive
Contributing Research Center
33.3
65
Contributing Research Center
33.3
66
Contributing Research Center
33.3
67
NCI Comprehensive
26.8
68
NCI Comprehensive
26.8
69
NCI Comprehensive
26.8
70
NCI Comprehensive
26.8
71
NCI Clinical
26.8
7226.8
7326.8
74
NCI Comprehensive
75
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →